The trial compared combination ratios, so its results cannot isolate the effect of increasing either drug alone.
Children aged one to six received one of three oral midazolam-esketamine combinations. The middle combination achieved sedation success in 71.8%, compared with 53.5% in the higher-midazolam combination and 68.2% in the higher-esketamine combination. Adverse events were more frequent in the higher-esketamine group. Success combined sedation, separation and mask-acceptance criteria.
The middle and higher-esketamine combinations did not differ significantly on success. Dose selection partly relied on unpublished pilot information. A single-center study in a narrow age range cannot establish a universally optimal regimen, and both active components changed across groups.
For expert review, report the comparison actually supported by the data rather than calling one regimen categorically best. Examine the complete success definition and adverse-event pattern. Route, age, timing and the paired drug ratio all matter when applying the results to a child’s perioperative course.
Source reviewed: Evaluation of optimal dosage combinations of oral midazolam and esketamine for pediatric preoperativ (PMC13049283). The forensic applications above are interpretive analysis of the supplied paper.
Related reading: Pediatric Bidirectional-Endoscopy Comparison Included Midazolam in Both Sedation Strategies.